Suppr超能文献

[心肾综合征:心力衰竭治疗中的挑战]

[Cardio-renal syndrome: the challenge in heart failure treatment].

作者信息

Martins Hélia, Pedro Nelson, Castellano Maria, Monteiro Pedro, Moura José Júlio, Providência Luís A

机构信息

Serviços de Cardiologia e de Medicina Interna, Hospitais da Universidade de Coimbra, Portugal.

出版信息

Acta Med Port. 2011 Mar-Apr;24(2):285-92. Epub 2011 May 20.

Abstract

Heart failure is a chronic and progressive disease that is estimated to affect approximately 20 million people worldwide and is one of the major public health problems. Its prevalence is reaching epidemic levels with about 550,000 new cases diagnosed annually, partly due to increased life expectancy in developed countries. And as it is a systemic disease, it can cause dysfunction in various organs, but especially in the kidney. The renal failure is often associated with heart failure and, when present together, make the treatment more complex and the prognosis is worse. This is the cardio-renal syndrome. The definition of cardio-renal syndrome varies according to the working groups, and there isn't a consensus. The exact cause of deterioration of renal function and the mechanism behind this interaction are complex, multifactorial in nature and not fully known at present. The treatment available is the one used for the treatment of heart failure. It is necessary to maintain the normal function of filtration, secretion and reabsorption in kidney to have a real improvement of the clinical condition of the patient. Patients with higher risk of developing nephropathy and those who have diagnosed renal failure should have prescribed drugs that are handled very carefully. But as in many other clinical situations, there aren't perfect drugs available to treat cardio-renal syndrome and the existing ones may have serious side effects in medium/long term causing the deterioration of renal function and possibly an increased mortality. The treatment is truly challenging in patients with severe fluid overload that is refractory to diuretics. This article aims to present the existing definitions of cardio-renal syndrome, its epidemiology, describe the current knowledge about the pathophysiology and its relationship to therapeutic interventions, some actual strategies and future technologies in an attempt to preserve the kidney, mainly during the decompensation of chronic heart failure.

摘要

心力衰竭是一种慢性进行性疾病,据估计全球约有2000万人受其影响,是主要的公共卫生问题之一。其患病率正达到流行程度,每年约有55万新病例被诊断出来,部分原因是发达国家预期寿命的延长。由于它是一种全身性疾病,可导致各个器官功能障碍,尤其是肾脏。肾衰竭常与心力衰竭相关,二者同时存在时会使治疗更加复杂且预后更差。这就是心肾综合征。心肾综合征的定义因工作组而异,尚无共识。肾功能恶化的确切原因及其相互作用背后的机制复杂,具有多因素性质,目前尚不完全清楚。现有的治疗方法是用于治疗心力衰竭的方法。有必要维持肾脏过滤、分泌和重吸收的正常功能,以使患者的临床状况真正得到改善。有更高肾病发病风险的患者以及已诊断为肾衰竭的患者,所开药物的使用应非常谨慎。但与许多其他临床情况一样,没有完美的药物可用于治疗心肾综合征,现有的药物可能在中长期产生严重副作用,导致肾功能恶化并可能增加死亡率。对于利尿剂难治的严重液体超负荷患者,治疗极具挑战性。本文旨在介绍心肾综合征的现有定义、流行病学,描述目前关于其病理生理学的知识及其与治疗干预的关系、一些实际策略和未来技术,以期主要在慢性心力衰竭失代偿期间保护肾脏。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验